A number of companies in health care-related industries launched IPO efforts during Q1. The final filing of the quarter came when orthopedic device maker Globus Medical submitted public offering documents to the SEC last week. Globus Medical, which has [...]
India, generic drugs, and patent protection
by ,
March 16, 2012, 2:26 PM
0March 16, 2012, 2:26 PM
India’s drug industry and the production of generic drugs have come into the spotlight recently as the country’s Supreme Court hears litigation from pharmaceutical giant Novartis over patent protection. India [...]
Indian spice element could help treat prostate cancer
by ,
February 14, 2012, 3:18 PM
0February 14, 2012, 3:18 PM
Some of my favorite pharma news stories come when natural remedies are tested as potential disease cures in modern medical research labs. A recent example comes from a group of Thomas Jefferson University [...]
Lipitor loses patent, but will the mighty Pfizer crumble?
by ,
November 30, 2011, 11:29 AM
1November 30, 2011, 11:29 AM
Yes, today is the day. Lipitor’s patent has officially expired, marking the largest patent loss to date and bringing unavoidable changes to top drugmaker Pfizer’s revenue base. Watson Pharmaceuticals takes [...]
Halting the Hepatitis C virus: Pharmasset drug shines in clinical trials
by ,
November 7, 2011, 2:39 PM
1November 7, 2011, 2:39 PM
The hepatitis C drug market is heating up once again as development firm Pharmasset announces study results showing a 100% success rate for its clinical-stage antiviral candidate. The results, which were presented [...]
Big Pharma layoffs continue with Novartis cuts
by ,
October 28, 2011, 10:12 AM
0October 28, 2011, 10:12 AM
Novartis stepped up to become the latest top drug company to announce layoffs this week. The move reinforces the common market belief that the pharmaceuticals industry will have to reshape itself [...]
Abbott Labs splits operations to reduce exposure to drug costs, risks
by ,
October 21, 2011, 1:50 PM
0October 21, 2011, 1:50 PM
Abbott Laboratories has a history of diversity, with operations ranging from medical equipment, diagnostic tests, nutritionals, and pharmaceuticals. Its breakup announcement this week boils down to the trouble that such [...]
FDA approves skin cancer drug, personalized medicine advances
by ,
August 18, 2011, 3:46 PM
0August 18, 2011, 3:46 PM
Personalized medicine scored a point this week when the FDA granted early approval for Zelboraf, a biotech drug that aims to treat metastatic melanoma patients with certain genetic traits. The approval of Zelboraf, [...]
Drug research quality drops, but costs keep rising
by ,
July 28, 2011, 9:41 AM
0July 28, 2011, 9:41 AM
The FDA has cited a small contract research firm, Cetero Research, for falsifying drug testing results. This news comes on top of reports that pharmaceutical research costs are steadily rising. Put [...]
Pfizer’s ‘virtual’ drug trial could reshape R&D processes
by ,
June 9, 2011, 11:52 AM
0June 9, 2011, 11:52 AM
Ever thought about answering one of those “Do you suffer from migraines?” or “Got bunions?” clinical trial ads, but just haven’t had the time or energy to enroll? Well, your [...]
Recent Comments